Oxfordshire UK [Marlborough, MA]; February 13, 2012 –
Oxford Immunotec Ltd. an immunology focused diagnostic company, announces the appointment of Richard (Rick) Altieri as Chief Financial Officer (CFO).
Prior to joining Oxford Immunotec, Mr. Altieri was Vice President and Chief Financial Officer of Salient Surgical Technologies, Inc. a medical technology company that develops and markets surgical advanced energy products. At Salient, he led all financing activities, prepared to take the company public and played a key role in the ultimate sale of the company to Medtronic. Before Salient, Rick was Senior Vice President of Finance and Chief Financial Officer of Straumann USA, a global leader in the field of implant dentistry and dental tissue regeneration. Previously, he was Vice President and Chief Financial Officer of Mitek Surgical Products, Inc., where he played a key role in the sale of the company to Johnson & Johnson. As part of the J&J family he was instrumental in Mitek’s subsequent growth into a leader in the field of surgical sports medicine. Rick is a CPA and earned his BS degree in Accounting from Northeastern University and an MBA from Babson College.
“I am very pleased that Rick has joined the organization,” commented Dr. Peter Wrighton-Smith, CEO of Oxford Immunotec. “Rick’s leadership and background with building high growth medical technology companies will be a tremendous asset to the organization as we continue to grow rapidly.”
– Ends –
